April Deng to Tumor Necrosis Factor-alpha
This is a "connection" page, showing publications April Deng has written about Tumor Necrosis Factor-alpha.
Connection Strength
0.267
-
Deng A, Harvey V, Sina B, Strobel D, Badros A, Junkins-Hopkins JM, Samuels A, Oghilikhan M, Gaspari A. Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors. Arch Dermatol. 2006 Feb; 142(2):198-202.
Score: 0.207
-
Bremmer M, Deng A, Gaspari AA. A mechanism-based classification of dermatologic reactions to biologic agents used in the treatment of cutaneous disease: Part 1. Dermatitis. 2009 Jul-Aug; 20(4):182-92.
Score: 0.016
-
Paltiel M, Gober LM, Deng A, Mikdashi J, Alexeeva I, Saini SS, Gaspari AA. Immediate type I hypersensitivity response implicated in worsening injection site reactions to adalimumab. Arch Dermatol. 2008 Sep; 144(9):1190-4.
Score: 0.015
-
Zhao Y, Fishelevich R, Petrali JP, Zheng L, Anatolievna MA, Deng A, Eckert RL, Gaspari AA. Activation of keratinocyte protein kinase C zeta in psoriasis plaques. J Invest Dermatol. 2008 Sep; 128(9):2190-7.
Score: 0.015
-
Sri JC, Tsai CL, Deng A, Gaspari AA. Osteomyelitis occurring during infliximab treatment of severe psoriasis. J Drugs Dermatol. 2007 Feb; 6(2):207-10.
Score: 0.014